Medtronic Reports Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/10/2026
- Wall Street ends down as expectations of Hormuz deal fade
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
Medtronic, Inc. (MDT) PT Raised to $99 at Jefferies; Q2 Eases Growth Concerns
November 22, 2017 7:45 AM ESTJefferies raised its price target on Medtronic, Inc. (NYSE: MDT) to $99.00 (from $96.00) while maintaining a Buy rating following Q2 results.
Analyst Raj Denhoy said the results eased concerns of a slowing growth trajectory.
"Despite weather impacts, F18 guidance for +4-5% sales and... More
Medtronic, Inc. (MDT) PT Bumped to $95 at Needham & Company
November 21, 2017 3:46 PM ESTNeedham & Company analyst Mike Matson bumped his price target on Medtronic, Inc. (NYSE: MDT) to $95.00 (from $94.00) while maintaining a Buy rating following Q1 results that beat the Street and reiterated guidance.
Matson notes organic revenue growth improved to 4.0% (excluding Hurricane Maria)... More
Medtronic (MDT) Tops Q2 EPS by 8c, Reiterates Guidance
November 21, 2017 6:48 AM ESTMedtronic (NYSE: MDT) reported Q2 EPS of $1.07, $0.08 better than the analyst estimate of $0.99. Revenue for the quarter came in at $7.1 billion versus the consensus estimate of $6.93 billion.
Guidance
Medtronic today reiterated its revenue and non-GAAP EPS guidance. The company's guidance is given on a comparable, constant currency basis, which accounts for the divestiture of certain businesses from its prior period Patient Monitoring & Recovery division by removing the financial impact... More
